For citations:
Avdeeva A.S., Artyukhov A.S., Dashinimaeva E.B., Cherkasova M.V., Nasonov E.L. Changes of cytokine profile measures during the treatment of rheumatoid arthritis with rituximab biosimilar (Acellbia, BIOCAD) and the original drug (MabThera, F. Hoffmann-La Roche Ltd., Switzerland). Rheumatology Science and Practice. 2019;57(1):46-55. (In Russ.) https://doi.org/10.14412/1995-4484-2019-46-55